Gestational diabetes mellitus (GDM) is a public health concern due to its long-term implications on mothers and infants. Every year, around 2-5% of pregnant women develop GDM, and the number may increase to 7-9%, including mothers with risk factors. Although pharmacological interventions may improve GDM, they are not sustainable. Hence, the first line of treatment should be lifestyle interventions since GDM is directly linked to adverse lifestyles.
Chellaram Diabetes Institute has organized the 5th International Diabetes Summit from 12th-14th March 2021 . Docplexus is the proud knowledge partner in this exclusive virtual event. To learn more about the non-pharmacological management and glucose monitoring of gestational diabetes, a session has been organized on 14th March 2021, 11:45 AM onwards. In this session, the experts will speak on the following topics: 11.45 AM-12.05 PM –…
